CMPK2 and COVID-19: Additionally, CMPK2, which is upregulated in COVID-19 patients’ leukocytes, may play key roles in antiviral immunity and has been positioned as a therapeutic target against SARS-CoV-2 and other RNA viruses (37, 38).